Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus Midazolam for sedation during upper GI endoscopy
2024-516432-94-00Phase 4Authorised
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and midazolam, sponsored by St. Antonius Ziekenhuis. Primary endpoint: Time to full alertness. Planned start Sep 2024; status: authorised.
02
Drugs
remimazolammidazolam
Beyond the preview
Go deeper on 2024-516432-94-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516432-94-00.